Post Doctoral Scientist – Targeting G-protein coupled receptors in human disease

Starting Salary £ 28,648 – £30,486

The MRC Toxicology Unit, located at the University of Leicester

The Medical Research Council Toxicology Unit, located at the University of Leicester, is an internationally renowned institution delivering field-changing mechanistic insights into toxicology and disease.

We are looking to appoint a post doctoral scientist to join the cell signalling group led by Professor Andrew Tobin to work on a project investigating the role of a family of G-protein coupled receptors called the free fatty acid receptor family and in collaboration with Professor Graeme Milligan and the pharmaceutical company Astra Zeneca. This project will investigate the basic biology of the FFAR-family of receptors and also establish, if targeting these receptors can be effective in treating human disease such as type II diabetes.

The successful candidate will join a highly experienced team of scientists involved in a broad range of cell signalling programmes from which they will gain novel techniques and progressive research approaches. This project specifically will use a range of techniques including molecular pharmacology, biochemistry and transgenic animals. There will also be the opportunity to work at the Astra Zeneca laboratories and at the University of Glasgow.

Candidates should have a PhD in a biological discipline, have a progressive and hard working approach to research and have published articles in international journals.

This is a four year position with a starting salary in the range £28,648 – £30,486 per annum.

For further information about the Toxicology Unit, please visit: http://tox.mrc.ac.uk/

Applications are handled by the UK Shared Business Services Ltd; to apply please visit our job board at http://www.topcareer.jobs/Vacancy/irc161093_4744.aspx. If you are unable to apply online please contact us on 01793 86700001793 867000 quoting reference IRC161093.

Closing date: 24 October 2014 
Interviews are expected to take place on 13th November 2014

The MRC Toxicology Unit is a member of Athena Swan.
The Medical Research Council is an Equal Opportunities Employer.